• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细胞培养的肠道通透性模型:述评

Cell culture-based models for intestinal permeability: a critique.

作者信息

Balimane Praveen V, Chong Saeho

机构信息

Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb, Princeton, NJ 08543, USA.

出版信息

Drug Discov Today. 2005 Mar 1;10(5):335-43. doi: 10.1016/S1359-6446(04)03354-9.

DOI:10.1016/S1359-6446(04)03354-9
PMID:15749282
Abstract

The model systems that are currently used to determine the intestinal permeability characteristics of discovery compounds often represent a combination of high-throughout, but less predictive, in silico and in vitro models and low-throughput, but more predictive, in vivo models. Cell-based permeability models have been integrated into the discovery paradigm for some time and represent the "method of choice" across the industry. Here, in addition to an objective analysis of the utility of cell culture models for permeability screening, anticipated future trends in the field of cell culture models are discussed.

摘要

目前用于确定研发化合物肠道通透性特征的模型系统通常是高通量但预测性较低的计算机模拟和体外模型与低通量但预测性较高的体内模型的组合。基于细胞的通透性模型已融入研发模式一段时间,是整个行业的“首选方法”。本文除了对细胞培养模型用于通透性筛选的效用进行客观分析外,还讨论了细胞培养模型领域预期的未来趋势。

相似文献

1
Cell culture-based models for intestinal permeability: a critique.基于细胞培养的肠道通透性模型:述评
Drug Discov Today. 2005 Mar 1;10(5):335-43. doi: 10.1016/S1359-6446(04)03354-9.
2
Mitigating permeability-mediated risks in drug discovery.减轻药物发现中渗透性介导的风险。
Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):171-87. doi: 10.1517/17425250903436486.
3
In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.用于药物“可开发性”评估的药物吸收体外测试:构建体外临床前数据与临床结果之间的桥梁
Curr Opin Drug Discov Devel. 2004 Jan;7(1):75-85.
4
Exploring the role of different drug transport routes in permeability screening.探索不同药物转运途径在渗透性筛选中的作用。
J Med Chem. 2005 Jan 27;48(2):604-13. doi: 10.1021/jm049711o.
5
Prediction of human pharmacokinetics--gastrointestinal absorption.人体药代动力学预测——胃肠道吸收
J Pharm Pharmacol. 2007 Jul;59(7):905-16. doi: 10.1211/jpp.59.7.0001.
6
Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation.肠道和血脑屏障细胞培养模型的验证及药物渗透比较。
ALTEX. 2004;21 Suppl 3:57-64.
7
Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).使用吸收-处置模型从Caco-2通透性估算人体药物口服吸收动力学:模型开发、评估以及ka和Fa的解析解推导
J Pharmacol Exp Ther. 2005 Jul;314(1):391-9. doi: 10.1124/jpet.104.076182. Epub 2005 Apr 15.
8
Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds.用于发现化合物高通量渗透性评估的96孔Caco-2细胞培养模型的验证
Int J Pharm. 2005 Jun 13;297(1-2):235-41. doi: 10.1016/j.ijpharm.2005.03.008. Epub 2005 Apr 11.
9
Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.使用蒙特卡罗方法生成类药物分子群体对被动肠膜通透性进行的理论研究。
Int J Pharm. 2009 May 21;373(1-2):55-61. doi: 10.1016/j.ijpharm.2009.02.002. Epub 2009 Feb 12.
10
[Marker transport across biological barriers in vitro: comparison of cell culture models for the gastrointestinal barrier, the blood-brain barrier and the alveolar epithelium of the lung].[体外标志物跨生物屏障的研究:胃肠道屏障、血脑屏障及肺肺泡上皮细胞培养模型的比较]
ALTEX. 2001;18(3):155-64.

引用本文的文献

1
Effect of ECM nanostructures in decellularized small intestine on differentiation of intestinal epithelial model cells.脱细胞小肠中细胞外基质纳米结构对肠上皮模型细胞分化的影响。
J Artif Organs. 2025 May 22. doi: 10.1007/s10047-025-01509-8.
2
Tumour necrosis factor-α induces macromolecule translocation in HIV-derived duodenal organoids.肿瘤坏死因子-α诱导HIV来源的十二指肠类器官中的大分子转运。
Front Immunol. 2025 Mar 18;16:1563702. doi: 10.3389/fimmu.2025.1563702. eCollection 2025.
3
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.
使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
4
Matrix-free human 2D organoids recapitulate duodenal barrier and transport properties.无基质的人类二维类器官可重现十二指肠屏障和转运特性。
BMC Biol. 2025 Jan 5;23(1):2. doi: 10.1186/s12915-024-02105-7.
5
Improving the Accuracy of Permeability Data to Gain Predictive Power: Assessing Sources of Variability in Assays Using Cell Monolayers.提高渗透率数据的准确性以获得预测能力:评估使用细胞单层进行的实验中的变异性来源。
Membranes (Basel). 2024 Jul 14;14(7):157. doi: 10.3390/membranes14070157.
6
Gallocin-derived Engineered Peptides Targeting EGFR and VEGFR in Colorectal Cancer: A Bioinformatic Approach.基于蜂毒素的靶向 EGFR 和 VEGFR 的工程化肽在结直肠癌中的应用:一种生物信息学方法。
Curr Top Med Chem. 2024;24(18):1599-1614. doi: 10.2174/0115680266295587240522050712.
7
Enhancing pre-clinical research with simplified intestinal cell line models.利用简化的肠道细胞系模型加强临床前研究。
J Tissue Eng. 2024 Mar 4;15:20417314241228949. doi: 10.1177/20417314241228949. eCollection 2024 Jan-Dec.
8
Screening oral drugs for their interactions with the intestinal transportome via porcine tissue explants and machine learning.通过猪组织外植体和机器学习筛选与肠道转运体相互作用的口服药物。
Nat Biomed Eng. 2024 Mar;8(3):278-290. doi: 10.1038/s41551-023-01128-9. Epub 2024 Feb 20.
9
Towards Full Thickness Small Intestinal Models: Incorporation of Stromal Cells.迈向全层小肠模型:基质细胞的掺入。
Tissue Eng Regen Med. 2024 Apr;21(3):369-377. doi: 10.1007/s13770-023-00600-6. Epub 2023 Dec 19.
10
Role of Stress on Driving the Intestinal Paracellular Permeability.应激对肠道细胞旁通透性的驱动作用。
Curr Issues Mol Biol. 2023 Nov 18;45(11):9284-9305. doi: 10.3390/cimb45110581.